| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9362502 | Otolaryngology - Head and Neck Surgery | 2005 | 7 Pages |
Abstract
PPAR γ activation represents a novel target for anti-cancer therapy for head and neck cancer and the current level of clinical toxicity of 4-HPR would be judged acceptable to utilize this agent alone or in combination chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
George MD, Raed Abu BS, David MD, Beverly BS, Frank G. MD, PhD,